Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia
Clinical trial NCT01310010 · COMPLETED
Trial details
- NCT number
- NCT01310010
- Sponsor
- Grupo Espanol de trasplantes hematopoyeticos y terapia celular
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2015-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.